These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 8550133)

  • 1. Pharmacokinetics of antipyrine and theophylline: unaltered by multi-dose omeprazole treatment in rabbits.
    Chandrashekhar SM; Chakrabarti A; Garg SK
    Indian J Physiol Pharmacol; 1995 Jul; 39(3):302-4. PubMed ID: 8550133
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of capsaicin on the pharmacokinetics of antipyrine, theophylline and quinine in rats.
    Wanwimolruk S; Nyika S; Kepple M; Ferry DG; Clark CR
    J Pharm Pharmacol; 1993 Jul; 45(7):618-21. PubMed ID: 8105056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No influence of single intravenous doses of omeprazole on theophylline elimination kinetics.
    Oosterhuis B; Jonkman JH; Andersson T; Zuiderwijk PB
    J Clin Pharmacol; 1992 May; 32(5):470-5. PubMed ID: 1587966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of acute phase response on the plasma clearance of antipyrine, theophylline, phenytoin and nifedipine in rabbits.
    Saitoh T; Kokue E; Shimoda M
    J Vet Pharmacol Ther; 2000 Jun; 23(3):153-8. PubMed ID: 11110102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of four lansoprazole dose levels and one dosage regimen of omeprazole on 24-hour intragastric pH in healthy subjects.
    Timmer W; Ripke H; Kleist P; Ehrlich A; Wieckhorst G; Lücker PW; Fuder H
    Methods Find Exp Clin Pharmacol; 1995 Sep; 17(7):489-95. PubMed ID: 8577212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of nifedipine on antipyrine and theophylline disposition.
    Adebayo GI; Mabadeje AF
    Biopharm Drug Dispos; 1990 Mar; 11(2):157-64. PubMed ID: 2183884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omeprazole weakly inhibits CYP1A2 activity in man.
    Rost KL; Fuhr U; Thomsen T; Zaigler M; Brockmöller J; Bohnemeier H; Roots I
    Int J Clin Pharmacol Ther; 1999 Nov; 37(11):567-74. PubMed ID: 10584979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the proton pump inhibitor omeprazole on the pharmacokinetics of extended-release formulations of oxybutynin and tolterodine.
    Dmochowski R; Chen A; Sathyan G; MacDiarmid S; Gidwani S; Gupta S
    J Clin Pharmacol; 2005 Aug; 45(8):961-8. PubMed ID: 16027408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Theophylline and antipyrine disposition in smoking and non-smoking epileptic subjects.
    Acheson DW; Uden S; Braganza JM; Brown SW; Houston JB
    Br J Clin Pharmacol; 1987 Dec; 24(6):812-5. PubMed ID: 3440101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of orally administered omeprazole on abomasal luminal pH in dairy calves fed milk replacer.
    Ahmed AF; Constable PD; Misk NA
    J Vet Med A Physiol Pathol Clin Med; 2005 Jun; 52(5):238-43. PubMed ID: 15943608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omeprazole alleviates benzo[a]pyrene cytotoxicity by inhibition of CYP1A1 activity in human and mouse hepatoma cells.
    Shiizaki K; Ohsako S; Kawanishi M; Yagi T
    Basic Clin Pharmacol Toxicol; 2008 Nov; 103(5):468-75. PubMed ID: 18793272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors contributing to the accelerated clearance of theophylline and antipyrine in adults with exocrine pancreatic disease.
    Acheson DW; Hunt LP; Rose P; Houston JB; Braganza JM
    Clin Sci (Lond); 1989 Apr; 76(4):377-85. PubMed ID: 2714050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of omeprazole on Helicobacter pylori urease activity in vivo.
    Stoschus B; Domínguez-Muñoz JE; Kalhori N; Sauerbruch T; Malfertheiner P
    Eur J Gastroenterol Hepatol; 1996 Aug; 8(8):811-3. PubMed ID: 8864680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative pharmacokinetics of theophylline in hyperlipidemia in animals and humans].
    Górnik W
    Ann Acad Med Stetin; 1996; 42():39-50. PubMed ID: 9199125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipyrine, theophylline, and hexobarbital as in vivo P450 probe drugs.
    Groen K; Breimer DD
    Methods Enzymol; 1996; 272():169-77. PubMed ID: 8791775
    [No Abstract]   [Full Text] [Related]  

  • 16. The effects of inhibiting cytochrome P450 3A, p-glycoprotein, and gastric acid secretion on the oral bioavailability of methadone in dogs.
    Kukanich B; Lascelles BD; Aman AM; Mealey KL; Papich MG
    J Vet Pharmacol Ther; 2005 Oct; 28(5):461-6. PubMed ID: 16207309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cimetidine impairs the elimination of theophylline and antipyrine.
    Bauman JH; Fuentes RJ
    Gastroenterology; 1982 Mar; 82(3):601-2. PubMed ID: 10336329
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of omeprazole administration on pancreatic content of enzymes in rats].
    Montagnini AL; Kubrusly MS; Coelho AM; Molan NA; da Cunha JE; Machado MC; Pinotti HW
    Rev Hosp Clin Fac Med Sao Paulo; 1995; 50(5):272-5. PubMed ID: 8578092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excessively high doses of omeprazole being used in infants.
    Kolos P
    J Paediatr Child Health; 2006 Nov; 42(11):746-7. PubMed ID: 17044910
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevalence of potential proton-pump inhibitor drug interactions: a retrospective review of prescriptions in community pharmacies.
    Saltiel E; Fask A
    Clin Ther; 1999 Oct; 21(10):1812-9. PubMed ID: 10566575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.